Staphylococcus aureus nasal carriage among outpatients attending primary health care centers: a comparative study of two cities in Saudi Arabia and Egypt  by Abou Shady, Hala M. et al.
b r a z j i n f e c t d i s . 2 0 1 5;1  9(1):68–76
The Brazilian Journal of
INFECTIOUS  DISEASES
www.elsev ier .com/ locate /b j id
Original article
Staphylococcus  aureus  nasal  carriage  among
outpatients attending  primary  health  care  centers:
a comparative  study  of  two  cities  in Saudi  Arabia
and Egypt
Hala M. Abou Shadya, Alaa Eldin A. Bakra,b,∗,
Mahmoud  E. Hashadc, Mohammad A. Alzohairyd
a Department of Microbiology, Faculty of Science, Ain Shams University, Cairo, Egypt
b Environmental Quality Sector, Egyptian Environmental Affairs Agency, Cairo, Egypt
c Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt
d Department of Medical Laboratories, College of Applied Medical Science, Qassim University, Qassim, Saudi Arabia
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 6 August 2014
Accepted  30 September 2014
Available  online 15 December 2014
Keywords:
Community acquired methicillin
resistant  Staphylococcus aureus
(CA-MRSA)
Outpatients  in Egypt and Saudi
Arabia
SCCmec typing
Spa  typing
a  b  s  t  r  a  c  t
Epidemiological and molecular data on community acquired methicillin resistant Staphy-
lococcus  aureus (CA-MRSA) are still scarce in both Egypt and Saudi Arabia. There is almost
no  data regarding methicillin resistant Staphylococcus aureus (MRSA) prevalence in both
countries.  This study was conducted to investigate the prevalence and molecular epidemi-
ology  of S. aureus and MRSA nasal carriage among outpatients attending primary health
care  centers in two big cities in both countries. A total of 206 nasal swabs were obtained,
103  swabs from each country. S. aureus isolates were characterized by antibiotic suscepti-
bility,  presence of mecA and PVL genes, SCCmec-typing and spa typing, the corresponding
Multi  locus sequence typing clonal complex was assigned for each spa type based on Ridom
StaphType  database. MRSA was detected in 32% of the Egyptian outpatients while it was
found  in 25% of the Saudi Arabian outpatients. All MRSA isolates belonged to SCCmec type
V  and IVa, where some isolates in Saudi Arabia remained nontypeable. Surprisingly PVL+
isolates were low in frequency: 15% of MRSA Egyptian isolates and 12% of MRSA isolates in
Saudi Arabia. Two novel spa types were detected t11839 in Egypt, and t11841 in Saudi Arabia.
We found 8 spa types among 20 isolates from Egypt, and 12 spa types out of 15 isolates from
Saudi  Arabia. Only two spa types t008 and t223 coexisted in both countries. Four clonal com-
plexes  (CC5, CC8, CC22, and CC80) were identiﬁed in both Egypt and Saudi Arabia. However,
the  data collected lacked a representation of isolates from different parts of each country
as  only one health center from each country was included, it still partially illustrates theCA-MRSA  situation in bot
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taphylococcus aureus is one of the most isolated bacterial
athogens in humans, while it is the causative agent of
 wide panel of infections ranging from superﬁcial lesions
o  life-threatening septicemia. Over the past decades it has
emained  among the top six clinically important pathogens.1,2
ethicillin resistant S. aureus (MRSA) has been recognized
s  the principal health-care associated pathogen (HA-MRSA)
orldwide. In the last two decades, community acquired
ethicillin resistant S. aureus (CA-MRSA) infections have
merged  as well.3,4 Moreover, CA-MRSA strains have been
eported  to be more  virulent than HA-MRSA strains.5 Carriage
f  S. aureus by humans is a natural phenomenon associ-
ted  with health and disease. Although multiple body sites
an  be colonized in human beings, the anterior nares are
he  most frequent carriage sites for S. aureus. It colonizes
he  nasal mucosa of approximately 30–50% of individu-
ls.  Nasal carriage of S. aureus is an important risk factor
or  a wide range of staphylococcal infections. Accord-
ngly, it has been widely used as an indicator to assess
ntibiotic resistance of S. aureus and MRSA in different
opulations.6,7
Molecular typing of MRSA is an important tool for epi-
emiological surveillance and for development of infection
ontrol  measures aimed at preventing the occurrence and
issemination of epidemic clones within hospitals, from the
ommunity  to hospitals, as well as within community. Sev-
ral  methods have been used for S. aureus typing. Spa typing
s  a reliable, accurate and discriminatory typing method of
RSA;  it is based on DNA-sequencing of the repeat region
f  the Staphylococcus protein A gene (spa), where repeats
re  assigned a numerical code and the spa-type is deduced
rom  the order of speciﬁc repeats. The concordance between
pa  typing and multilocus sequence typing (MLST) has been
onﬁrmed,  and consequently spa typing could be used to
redict  multilocus sequence typing clonal complexes (MLST
Cs)  deﬁned by eBURST software.8 On the other hand, the
easibility  of spa typing as a more  expedite and less tech-
ically  demanding alternative typing method for MRSA has
een  demonstrated in Canada based on the observed concor-
ance  of spa types with pulsed-ﬁeld electrophoresis (PFGE) for
anadian types of epidemic MRSA.9 Moreover, Vincent et al.
2013)  reported on the cost-effectiveness of spa, Staphylococ-
us  chromosomal cassette (SCCmec), and Panton-Valentine
eukocidin (PVL) genotyping of MRSA in relation to PFGE and
LST.10
Since its ﬁrst description, infections caused by CA-MRSA
trains have been reported worldwide.11,12 In both Egypt
nd  Saudi Arabia, data on carriage, prevalence and geno-
yping  of CA-MRSA are still scarce.13,14 The objective of
his  study was  to characterize the MRSA clones dissem-
nation among outpatients attending primary health care
enters  in both countries. In order to characterize the
RSA  strains, different molecular typing methods were
sed  including SCCmec typing, spa-typing and the corre-
ponding multilocus sequence typing (MLST) and clonal
omplex based on the spa types in the Ridom StaphType
atabase. 1 5;1  9(1):68–76  69
Materials  and  methods
Study  area  and  study  population
A cross-sectional descriptive study was conducted from July to
October 2011 on a community sample from Al-kanater Alkhyria
city,  Egypt and Buraydah city, Saudi Arabia. Al-Kanater Alkhyria
is  one of the major cities in Al-Qalyubia governorate, located
about  22 km north of Cairo, the capital city of Egypt. Buraydah
city  is the capital city of AL-Qassim district, located 350 km
north  of Riyadh, the capital city of Saudi Arabia. We  randomly
collected nasal swabs from 206 outpatients, 103 from each
city.  All swabs were  taken from outpatients attending primary
health  care centers which are staffed by a group of general
practitioners and nurses, delivering services that include fam-
ily  practice, pediatrics, women’s care, family planning and
dental  care. All outpatients included had no history of MRSA
infection,  hospital admission or nursing home during the pre-
vious year, surgery, dialysis, permanent indwelling catheters,
or  medical devices inserted through the skin. The objectives
of  the study were explained for the participants, who  have
accepted  to take nasal swabs. For Egyptian outpatients (EGOs),
there  were 69% females and 31% males, age ranges from six
months  to 59 years. For Saudi Arabian outpatients (SAOs), 70%
were females and 30% males, age ranges from six months to
60 years.
Specimen  collection  and  screening  for  nasal  carriage
Specimens were  collected from both anterior nares using ster-
ile  cotton swabs moistened with sterile solution of normal
saline.  All swabs were  kept at 4 ◦C for 24 h until processing in
the  laboratory. Each swab was inoculated in tryptic soya broth
(Oxoid)  and incubated overnight at 37 ◦C to increase the isola-
tion  rate of S. aureus. The broth was  subcultured on mannitol
salt  agar (Oxoid) plates and incubated aerobically at 37 ◦C for
48  h. All presumptive S. aureus colonies were  identiﬁed based
on  colony morphology, Gram staining, production of catalase,
tube  coagulase, and DNase test. All S. aureus isolates were  pre-
served  in glycerol and stored at −80 ◦C for further experiment.
Antimicrobial  susceptibility  testing
All S. aureus isolates were subjected to antimicrobial sus-
ceptibility  testing by the standard agar disk diffusion
methodology according to Clinical and Laboratory Stan-
dards  Institute (CLSI). The following panel of antibiotics
were used: oxacillin, cefoxitin, vancomycin, erythromycin,
clindamycin, gentamycin, trimethoprim-sulphamethoxazole,
chloramphenicol, ciproﬂoxacin, tobramycin, moxiﬂoxacin,
and  rifampicin. All oxacillin and cefoxitin resistant isolates
were  further conﬁrmed as methicillin resistant by the ability
of  the isolates to grow on Muller–Hinton agar supplemented
with 4% sodium chloride and 6 g/mL oxacillin.15,16Molecular  characterization
Both methicillin resistant and susceptible Staphylococcus
aureus isolates were  grown in tryptic soya broth at 37 ◦C
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overnight, bacterial cells were harvested in 2.0 mL  Eppen-
dorf  tubes by centrifugation at 10,000–15,000 × g for 10–15 min,
genomic  DNA was  extracted using miniprep extraction
method which was  previously described by Wilson.17 The
extracted  DNA had kept under (−20 ◦C) for further experi-
ments.
All  S. aureus isolates were  conﬁrmed by PCR ampliﬁca-
tion of the nuclease gene (nuc gene) using primers previously
described.18 Then, all suspected methicillin resistant and sus-
ceptible  Staphylococcus aureus isolates were examined by PCR
for  the presence of mecA (methicillin resistance) and PVL
(Panton-Valentine Leukocidin) genes using the protocol pre-
viously  described.19 The SCCmec typing was  performed for all
MRSA  isolates using a multiplex PCR assay described previ-
ously  by Zhang et al.20
Spa typing was  performed for randomly selected 20 MRSA
isolates  from Egypt, and 15 MRSA isolates from Saudi Arabia.
PCR  ampliﬁcation was  performed as described previously. The
PCR  product was  puriﬁed using the QIAquick PCR Puriﬁcation
Kit  (QIAGEN, Hilden, Germany) and sequenced with the Big
Dye  Terminator v1.1 Cycle Sequencing kit (Applied Biosystems
Warrington, UK). The sequencing products were puriﬁed with
a  DyeEx 2.0 Spin Kit (QIAGEN) and then prepared for running
on  an ABI 3100 Avant Genetic Analyzer in accordance with
the  manufacturer’s (Applied Biosystems) instructions.21,22 The
sequences  were  analyzed and A phylogenetic analysis of spa
sequences  was  performed where A Neighbor-joining tree was
constructed  from spa gene sequences using the BioNumer-
ics  software version 7.1 (APPLIED MATHS, Austin, USA). The
concordance  between spa typing and MLST was  evaluated pre-
viously. Faria et al.8 have concluded that spa typing could
be  used to predict MLST CCs deﬁned by eBURST. The cor-
responding MLST and MLST CCs was  assigned for each spa
type  based on the spa types in the Ridom StaphType database
(http://spa.ridom.de/spatypes.shtml)  and on the study by
Monecke et al., 2011.23
Results
Antimicrobial  susceptibility
All S. aureus isolates from both Egypt and Saudi Arabia
were  susceptible to ciproﬂoxacin, tobramycin, and mox-
iﬂoxacin.  Among MRSA isolates from EGOs 55% showed
resistance to erythromycin, 48% to chloramphenicol, 48%
to  trimethoprim-sulfamethoxazole, 33% to clindamycin, 33%
to gentamycin, 9% to vancomycin. Among MSSA isolates
57%  were  susceptible to all antibiotics used in this study,
while  24% showed resistance to erythromycin, 24% to
trimethoprim-sulfamethoxazole, 19% to gentamycin, 19% to
chloramphenicol (Table 1). Among MRSA isolates from SAOs
58%  showed resistance to erythromycin, 50% to chloram-
phenicol, 46% to trimethoprim-sulfamethoxazole, 11% to
clindamycin,  27% to gentamycin, 4% to vancomycin. Among
MSSA  isolates 63% were susceptible to all used antibi-
otics, while 25% showed resistance to erythromycin, 25% to
trimethoprim-sulfamethoxazole, 13% to gentamycin, 13% to
chloramphenicol (Table 1). 0 1 5;1  9(1):68–76
S.  aureus  and  MRSA  carriers
All S. aureus isolates were  further conﬁrmed by the presence
of  nuclease gene. Presence of mecA gene was  the ﬁnal marker
for  conﬁrming MRSA isolates. Out of 103 screened EGOs, S.
aureus  nasal carriers were  detected in 54 (52%) being MRSA in
33 carriers (61% of S. aureus carriers and 32% of all isolates).
For  SAOs, 50/103 (48.5%) were S. aureus carriers being MRSA in
26 outpatients (52% of S. aureus carriers and 25% of all isolates)
(Fig.  1).
Presence  of  PVL  gene
Out of 33 MRSA isolates from EGOs, 5 (15%) were PVL positive,
and  out of 21 MSSA isolates 2 (9.5%) were PVL positive. Out of
26  MRSA isolates from SAOs, 3 (11.5%) were PVL positive, and
out  of 24 MSSA isolates 2 (8%) were  PVL positive (Fig. 1).
SCCmec  typing
Among Egyptian MRSA isolates there were 17 (51.5%) isolates
belonging  to SCCmec type V, and 16 (48.5%) to SCCmec type
IVa.  Among Saudi Arabian MRSA isolates there were  11 (42%)
isolates  belonging to SCCmec type V, and 6 (23%) to SCCmec
type  IVa, while 9 (35%) isolates remained nontypeable.
Spa  typing
Spa typing was performed in randomly selected 20 isolates
(60.6%  of all MRSA isolates) from Egypt, and in 15 isolates
(57.6% of all MRSA isolates) from Saudi Arabia. We  found
eight  different spa types among the 20 Egyptian MRSA spa
sequences,  and 12 different spa types out of the 15 Saudi Ara-
bian  MRSA isolates spa sequences (Fig. 2). Two novel spa types
t11839  in Egypt and t11841 in Saudi Arabia were  detected and
reported  to RIDOM spa server. Only two spa types t008 and
t223  coexisted in both countries with high frequency of t008
in  Saudi Arabia but low frequency in Egypt, all other spa types
were  different. Six more  spa types were identiﬁed in Egypt,
while  10 more  spa types were observed in Saudi Arabia (Fig. 2).
Corresponding  clonal  complex
The Egyptian MRSA isolates were associated with six clonal
complexes including CC5 (t688), CC8 (t008), CC22 (t223), CC30
(t021,  t318), CC80 (t044), CC88 (t786), while one spa type was
not  assigned while it was  a novel type (t11839). Among MRSA
from  Saudi Arabia, the isolates were assigned to seven clonal
complexes  including CC5 (t002), CC8 (t008), CC15 (t084, t084),
CC22  (t223), CC25 (t349, t660), CC80 (t376), CC188 (t189). In addi-
tion,  three spa types were not yet assigned, and one of them
was  a novel spa type. Four clonal complexes (CC5, CC8, CC22,
and  CC80) were identiﬁed in both Egypt and Saudi Arabia;
other  clonal complexes were different (Table 2).Discussion
This study, to the best of our knowledge, represents the ﬁrst
report  on molecular characteristics of CA-MRSA recovered
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Table 1 – Antimicrobial susceptibility proﬁle of MRSA and MSSA isolates in Egypt and Saudi Arabia.
Proﬁle OX FOX E CM GM VA C SXT RD CIP TOB MXF Egyptian
isolates
Saudi Arabian
isolates
I R R S S S S S S S S S S 9 8
II R R R S S S R R S S S S 7 9
III R R S R S S R R S S S S 2 0
IV R R S S R S S S S S S S 2 3
V R R R S R S R S S S S S 4 3
VI R R R R S S S R S S S S 4 2
VII R R S R R S S S S S S S 2 0
VIII R R R R R R R R R S S S 3 1
IX S S S S S S S S S S S S 12 15
X S S S S R S R S S S S S 4 3
XI S S R S S S S R S S S S 5 6
R, resistant; S, susceptible; OX, oxacillin; FOX, cefoxitin; E, erythromycin; CM, clindamycin; GM, gentamycin; VA, vancomycin; C, chlorampheni-
col; SXT, trimethoprim-sulfamethoxazole; RD, rifampicin; CIP, ciproﬂoxacin; TOB, tobramycin; MXF, moxiﬂoxacin.
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Table 2 – Molecular characters of randomly selected MRSA Isolates in Egypt and Saudi Arabia.
Isolates MLST CCs (incidence rate%) Spa type No. of Isolates SCCmec PVL
Egyptian spa typed isolates CC5  (30) t688 6 V Neg
CC8(5) t008 1 V Pos
CC22(10) t223 1  V Neg
1  IVa Neg
CC30(20) t021  2 IVa Neg
t318 1  IVa Neg
1  IVa Pos
CC80(15) t044 1  IVa Pos
2  V Pos
CC88(15) t786 2  IVa Neg
1 IVa Neg
NA(5) t11839 1 V Neg
Saudi Arabian spa typed
isolates
CC5(6.66)  t002 1 V Neg
CC8(13.33) t008 2 V Neg
CC15(26.66) t084 1  IVa Neg
1  V Neg
t085 2 V Neg
CC22(6.66) t223 1 V Neg
CC25(13.33) t349  1 V Neg
t660 1 IVa Neg
CC80(6.66) t376 1 Nontypeable Pos
CC188(6.66) t189 1 V Neg
NA(6.66) t442 1 IVa Neg
NA(6.66) t6836 1 Nontypeable Pos
NA(6.66) t11841 1 IVa Pos
MLST CC, multilocus sequence typing clonal complex (supposed allocations was based on the Ridom spa database and Monecke et al.23from anterior nares of outpatients attending health care
centers  in both Egypt and Saudi Arabia.13,14 We found a
high  carriage rate of S. aureus in EGOs and SAOs, whereas
MRSA carriage rate was  slightly higher in Egypt (32%) than
in  Saudi Arabia (25%). The high carriage rate is compatible
with the reported worldwide trend in increasing CA-MRSA
infections.11,12 In a recent report from Saudi Arabia, 26 studies
on  MRSA prevalence in ﬁve KSA regions were  analyzed since
2002  to 2012. Consequently, the overall mean estimation of
MRSA  prevalence was 35.6%, where MRSA prevalence varied
among  regions. Surprisingly, there were  no data regarding
MRSA  prevalence in Al-Qassim region.14,24 In Egypt, CA-MRSA
carriage rate in our study was  lower than the percentage
of  CA-MRSA (47.37%) in a sample of outpatients with skin
and  soft tissue infections who attended the dermatology
department of a medical school in Alexandria university.25
In addition, other studies have reported MRSA prevalence in
excess of 50%, but this study has mostly included hospital
inpatients.25 On the other hand, the carriage rate observed in
this  study is higher than previously reported rates from other
countries  in the Middle East area.24,26
Several factors could have been responsible for the higher
carriage  rate of CA-MRSA including the overconsumption
of antibiotics in both Egypt and Saudi Arabia, which is a
contributing factor for multidrug resistant bacteria. Several
reports  have found a positive correlation between S. aureus
resistance  to methicillin and consumption of beta-lactam
combinations.27,28 Other factors include overcrowding, poor
hygiene,  nutritional status, prevalence of parasitic infections,
hot  and humid weather, and presence of foreign labor andforeign  tourists, which have different degrees of priorities in
both  countries.29
Among antimicrobial susceptibility phenotypes, a low per-
centage  of isolates showed multiresistance. This was expected
from  community isolates. All Egyptian MRSA isolates were
found  to carry either type V or IVa SCCmec. The case was
the  same for Saudi Arabian MRSA isolates, but nearly 35% of
the  isolates remained nontypeable. This conﬁrms that MRSA
strains  are community strains and conﬁrm the tendency of
CA-MRSA  spreading among outpatients. We have found that
PVL+ isolates were  low in frequency, while PVL− isolates were
predominant in both countries. This supports the hypothesis
that  PVL gene is not necessarily the key factor in determin-
ing  CA-MRSA strains, and it does not play a greater role in
increasing  dissemination of these strains. Several studies have
reported the predominance of PVL− strains among the CA-
MRSA  isolates.30–34
In this study, four clonal complexes were identiﬁed in both
Egypt  and Saudi Arabia including (I) CC5-V-PVL negative (t688)
found  in high rate (30%) in Egyptian MRSA isolates, while it
was  present with low incidence rate in Saudi MRSA isolates as
(t002), CC5 was  a common and widespread CA-MRSA clonal
complex.  It has been described in Australia, Ireland, Germany
and  Abu Dhabi (23), Israel with high incidence rate,35 Gaza
Strip,36 and Tunisia.37 (II) CC8-V-PVL positive (t008) was  found
in  Saudi Arabia with high incidence and as PVL positive and
low  incidence in Egypt. CC8 is a pandemic MRSA lineage,
which is the predominant strain in the USA; CC8-MRSA-V has
been  reported in Pakistan,14 Europe,12 Denmark, Germany and
Australia.23 (III) CC22-V-PVL negative, and CC22-IVa-PVL negative
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Fig. 5 – Phylogenetic similarity of MRSA isolates from Egyptian (EG) and Saudi Arabian (SA) outpatients. A Neighbor-joining
tree was  constructed using spa gene sequences. The sequences analyzed using the BioNumerics software version 7.1
(APPLIED MATHS, Austin, USA).
(t223), PVL-negative, CC22-IV represent a HA-MRSA pandemic
strain  known as UK-EMRSA-15, or Barnim Epidemic Strain. A
recent report from Gaza Strip36 have highlighted the pres-
ence  of CC22-MRSA-IV-PVL negative (t223) in 64% of MRSA
isolates,  and showed also the presence of CC22-V-PVL neg-
ative  but in low incidence. This strain is common in Western
Europe  and has also been reported in many  countries includ-
ing  Malta, Kuwait, Abu Dhabi, India,23 and Tunisia.37 Sporadic
cases  of a PVL-negative CC22-MRSA-V have been identiﬁed in
Germany.23 IV.CC80-Iva-PVL+ (t044) has been found in Egypt
at  low incidence rate, CC80-PVL+ (t376) with nontypeable
SCCmec has been found in Saudi Arabia also at low inci-
dence  rate. PVL-positive CC80-MRSA-IV has been described asthe European CA-MRSA clone. This strain is widespread and
has  been isolated from different countries in Europe,12,23 Gaza
strip,36 Kuwait14 and Tunisia.37
In Egypt, two more  clonal complexes were  observed,
CC30-IVa-PVL-negative, PVL-positive (t021, t318) and CC88-
IVa-PVL-negative (t786) with an incidence rate of 20% and
15%.  CC30 is another important clonal complex from which
CA-MRSA  originate. A PVL-negative strain of ST30-MRSA-IV
is  sporadically isolated in Ireland and Australia.23 Another
important CC30-MRSA strain is the PVL-positive ST30-MRSA-
IV,  Southwest Paciﬁc Clone, which is widespread in Germany,
Switzerland, the UK and Australia.23 Several different CA-
MRSA  belong to CC88, which appears, based on spa sequences
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nd hybridization proﬁle, closely related to CC1 and CC80.
VL-negative CC88-MRSA-VI has been identiﬁed sporadically
n  Western Australia,23 and has been recently reported in the
iddle  east; Gaza strip36 and Africa; Gabon, Gulf of Guinea.38,39
In Saudi Arabia, three more  clonal complexes were
bserved: CC15-IVa-PVL-negative, CC15-V-PVL-negative (t084,
085) with a 27% incidence rate, CC15-MRSA has been detected
n  a collection of Italian MRSA strains isolated in 1980.23 It
as  reported in a recent study of S. aureus isolates from 16
f  the most populous European countries with high incidence
ates,12 Iran in Asia,40 and Gabon, Tunisia and Gulf of Guinea
n  Africa.37–39 CC25-IVA-PVL-negative, CC25-V-PVL-negative
ith a 13% incidence rate. CC25 was  previously reported in
urope,12 Iran in Asia,40 and Gabon in Africa.39 ST188-MRSA-
V has been found sporadically in Australia, other ST188-MRSA
ave  been observed in Asian countries: ST188-MRSA-III/spa
189 in Korea, PVL-negative CC188-MRSA-V in Hong Kong, and
VL-positive  ST188-MRSA-V in Malaysia.23
Spa typing reﬂects a high genetic diversity for MRSA iso-
ates  in Saudi Arabia comparing to that in Egypt. There was  a
lose relationship observed when phylogenetic analysis of spa
equences executed for each country alone using the BioNu-
erics  software version 7.1 (APPLIED MATHS, Austin, USA),
urprisingly;  Phylogenetic analyses of all spa types from both
ountries  revealed a close relationship among both Egypt and
audi  Arabia MRSA isolates (Figs. 3–5). This may  be referred
o  the high traveling rate from Saudi Arabia to Egypt and Vice
ersa  which consider a way  of transmission of different clones
etween  countries.
In  this study, we  have tried to delineate molecular epi-
emiological features that MRSA isolates of outpatients have
n  common with those in other parts of the world, while
ighlighting unique features of both Egyptian and Saudi Ara-
ian  isolates. With global transmission of MRSA, the local
pidemiology of both countries may  be changing due to the
ntroduction  of new strains. Our study has some limitations
oncerning the extent of representation of the MRSA popu-
ation  in both Egypt and Saudi Arabia. First, our data were
ollected in health centers of speciﬁc locations in each coun-
ry  that might not be representative of isolates from different
arts  of each country. Second, despite the collection instruc-
ions,  we  were  not able to categorize outpatients according to
hronic or acute diseases they had, because such information
as  not provided by the physicians who collected nasal swabs.
In  conclusion, MRSA still remains a signiﬁcant public
ealth problem. Surveillance is regarded as a means of gener-
ting  ‘information for action’. In terms of MRSA, coordinated
urveillance across Middle-east area is strictly needed, while
nformation  is still scarce in this area of the world. On the
ther  hand, measures to control the spread of MRSA must be
outinely applied. Furthermore, reducing the selective pres-
ure  for emergence and persistence of MRSA associated with
veruse  of antibiotics by improving antibiotic prescribing will
mprove the situation.onﬂicts  of  interest
he authors declare no conﬂicts of interest.
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